Trastuzumab Not Yet Recruiting Phase 3 Trials for Stage IV Breast Cancer / Stage IIIC Breast Cancer AJCC v7 / Stage IV Breast Cancer AJCC v6 and v7 / Stage IIIB Breast Cancer AJCC v7 / Stage IIIA Breast Cancer AJCC v7 / Stage III Breast Cancer AJCC V7 / HER2/Neu Positive / Recurrent Breast Carcinoma / Breast Adenocarcinoma Treatment

Indications	Status	Purpose	Phase
DBCOND0028550 (Stage IV Breast Cancer) DBCOND0092288 (Stage IIIC Breast Cancer AJCC v7) DBCOND0092437 (Stage IV Breast Cancer AJCC v6 and v7) DBCOND0092287 (Stage IIIB Breast Cancer AJCC v7) DBCOND0092286 (Stage IIIA Breast Cancer AJCC v7) DBCOND0037625 (Stage III Breast Cancer AJCC V7) DBCOND0037939 (HER2/Neu Positive) DBCOND0030216 (Recurrent Breast Carcinoma) DBCOND0029215 (Breast Adenocarcinoma)	Not Yet Recruiting	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT03199885	Paclitaxel, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Patients With Metastatic Breast Cancer	Trastuzumab (DB00072) Paclitaxel (DB01229) Pertuzumab (DB06366) Atezolizumab (DB11595)